Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

Echo® MS System for high-throughput analysis

2 Nov 2020
Written by SCIEX
Drug development MS (LC–MS/MS, HRMS, IMS)

This presentation outlines the analytical challenges in MS-based screening, acoustic ejection mass spectrometry technology and the application of the Echo® MS System beyond drug discovery and development.

 

SPOTLIGHT-Echo-MS press-release slides-Chang-min


This content was supplied by SCIEX. 

Top content

  • Newborns and people with Alzheimer’s share a surprising biomarker
  • A pivotal peril of profoundly pernickety peptides
  • Mastering bioanalytical project management

Related tags

LC-MS sciex
Previous article Next article

Related articles

19 SEP 2019 AN AUTHOR'S PERSPECTIVE
Yie Hou Lee on retention time bracketing for targeted sphingolipidomics by LC–MS/MS
31 OCT 2009 CHROMATOGRAPHY
Conference Report: 10th Annual University of Wisconsin Land O'Lakes Bioanalytical Conference
28 FEB 2011 CHROMATOGRAPHY
Conference Report: Chemical and Pharmaceutical Structure Analysis 2010: From Data to Biology: Analytical Measurements to Drive Pharmaceutical R&D
23 JAN 2014 JOURNAL ARTICLES
2013 White Paper on recent issues in bioanalysis: ‘hybrid’ – the best of LBA and LCMS
3 AUG 2022 JOURNAL ARTICLES
Large molecule bioanalysis by LC–MS: beyond simply quantifying
6 OCT 2022 INTERVIEWS
The significance of smart biomarker assays: an interview with Sharon DeChenne
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone